News for '-elara-securities'

Nykaa's revival rests on more than just growth

Nykaa's revival rests on more than just growth

Rediff.com17 Feb 2026

Strong performance in the beauty and personal care (BPC) segment, margin gains, and expectations of a breakeven in the fashion business lifted sentiment for FSN E-Commerce Ventures (Nykaa). The consumer technology platform's stock rose 7.5 per cent on Friday, extending gains over the past week to more than 17 per cent. Most brokerages have upgraded the stock following its third-quarter (October-December/Q3) performance and higher profit expectations ahead.

Volume, margin concerns likely to weigh on beer maker United Breweries

Volume, margin concerns likely to weigh on beer maker United Breweries

Rediff.com27 Dec 2025

The stock of the country's largest beer maker, United Breweries (UBBL), is trading at 25-month lows given multiple headwinds related to volumes, regulatory issues, and margin trajectory. After a muted second quarter (July-September) of 2025-26 (Q2FY26), brokerages also expect the company's Q3FY26 performance to be underwhelming.

Foreign investors withdrew record Rs 1.6 lakh cr from Indian equities in 2025

Foreign investors withdrew record Rs 1.6 lakh cr from Indian equities in 2025

Rediff.com28 Dec 2025

Foreign investors fled Indian equities in 2025 at a scale never seen before, pulling out a record Rs 1.6 lakh crore (USD 18 billion) as volatile currency movements, global trade tensions, especially potential US tariffs, and stretched valuations eroded risk appetite, though flows are expected to turn sustainably positive in 2026.

Strong therapies, JB to lift Torrent Pharma

Strong therapies, JB to lift Torrent Pharma

Rediff.com18 Nov 2025

A strong performance in the July-September quarter of 2025-26 (FY26) and expectations of growth from launches and acquisition-led synergies led to a 6.65 per cent jump in the share price of Torrent Pharmaceuticals.

Weak guidance may hit Sun Pharma in FY26

Weak guidance may hit Sun Pharma in FY26

Rediff.com1 Jun 2025

Despite a healthy performance in the fourth quarter of 2024-25 (Q4FY25), the stock of India's largest listed pharma company, Sun Pharmaceutical Industries (Sun Pharma), was under pressure on Friday due to a muted guidance. The company has guided for a high single-digit revenue growth for FY26, which is below what the Street was working with.

Paint major Berger's palette finds contrast in a washed-out quarter

Paint major Berger's palette finds contrast in a washed-out quarter

Rediff.com26 May 2025

Listed paint majors posted another lacklustre showing in the January-March quarter (Q4) of 2024-25 (FY25), with average revenue growth under 3 per cent. Sales were weighed down by Asian Paints - the market leader and the only major to report a year-on-year (Y-o-Y) decline.

Q4 result preview: Banks' net profit likely fell 4% on NIM pressure

Q4 result preview: Banks' net profit likely fell 4% on NIM pressure

Rediff.com15 Apr 2025

Net profit of 19 listed banks is likely to decline by 4 per cent year-on-year (Y-o-Y) for the quarter ended March (Q4FY25) mainly due to pressure on net interest margins (NIM) as a result of rate cut by the Reserve Bank of India (RBI), according to analysts' estimates. Additionally, loan growth is expected to further slowdown amid low demand in certain secured products, stress in the unsecured segment, and a high cost to deposit (CD) ratio across the system.

Why Havells India stock is likely to lose spark

Why Havells India stock is likely to lose spark

Rediff.com29 Jan 2025

Havells India, the country's largest listed consumer electrical company, reported a mixed performance in the 2024-25 (FY25) October-December quarter (Q3). While the top line benefited from festival demand, lower margins impacted operational performance.

The side effects are real, but Sun Pharma stays on its feet

The side effects are real, but Sun Pharma stays on its feet

Rediff.com21 Apr 2025

After falling 17 per cent since the start of the year to its March lows, the stock of the country's largest pharmaceutical (pharma) company, Sun Pharmaceutical Industries, has clawed back nearly half of those losses. Recent acquisitions, a favourable court ruling in the case of the hair loss drug Leqselvi, an edge over peers owing to its specialty portfolio, and a diversified global presence have supported the recovery.

Catalyst behind defence sector stocks regaining ground

Catalyst behind defence sector stocks regaining ground

Rediff.com24 Mar 2025

After lagging behind the broader market over the past three and six months, defence sector stocks have regained ground, reversing their performance from the past month. Concerns about slowing order inflows, execution hurdles, supply chain disruptions, and high valuations had weighed on the sector.

Shoe pinches for most large footwear companies

Shoe pinches for most large footwear companies

Rediff.com11 Mar 2025

Footwear companies were among the weakest performers in the consumer discretionary sector during the October-December quarter (Q3) of 2024-25. The combined revenue growth of the top four listed firms was just 2.9 per cent year-on-year (Y-o-Y) - the lowest among major discretionary categories.

India vs China: How leading brokerages are positioned across Asian equities

India vs China: How leading brokerages are positioned across Asian equities

Rediff.com18 Oct 2024

The recent stimulus measures announced by China have seen most analysts sit up and take notice.

M&A wave set to sweep over South cement market, say industry experts

M&A wave set to sweep over South cement market, say industry experts

Rediff.com6 Aug 2024

UltraTech Cement's announcement that it would snap up a controlling stake in India Cements may only be a sign of more to come. In the wake of one of the country's most expensive deals in recent times, cement majors may slug it out to add smaller firms from the region to their portfolio. UltraTech's buy is the latest in the four deals the southern market has seen in less than a year, with Adani Cement being the other buyer.

India Inc earnings slow down in Q1FY25 despite margin gains

India Inc earnings slow down in Q1FY25 despite margin gains

Rediff.com23 Aug 2024

After four years of high double-digit growth in profits, corporate earnings of Indian companies hit a speed bump in the April-June quarter of 2024 (Q1FY25), leading to the risk of a downward revision in India Inc profit estimates for FY25 and volatility in the equity market. Earnings growth slowed despite companies in most non-financial sectors reporting higher operating margins from lower commodity prices and a decline in interest costs.

Large order book, EV demand drive auto parts maker Sona BLW growth

Large order book, EV demand drive auto parts maker Sona BLW growth

Rediff.com28 May 2024

Auto parts maker Sona BLW Precision Forgings (Sona) reported strong revenue in the fourth quarter of financial year 2023-24 (Q4FY24) as demand for electric vehicles expands. The company reported a 19 per cent year-on-year (Y-o-Y) increase in sales to beat street estimates. Sales were powered by a 34 per cent growth in the battery electric vehicle (BEV) segment and a good show in the differential gear segment.

FMEG: Most brokerages positive on cable & wires business

FMEG: Most brokerages positive on cable & wires business

Rediff.com18 Mar 2023

With raw material prices rising sequentially in Q4 FY23, margins of fast moving electrical goods (FMEG) companies could witness pressure as they refrain from hiking prices and demand remains soft. Transition to a new regulatory regime-fans moved to new BEE standards from January 1-poses additional risk for firms. Business depends on volume trends in summer for key sub-segments, which account for a significant chunk of the sector's overall sales pie.

Predictions of normal monsoon boost prospects for domestic agrochem firms

Predictions of normal monsoon boost prospects for domestic agrochem firms

Rediff.com25 Apr 2024

https://www.rediff.com/business/report/quality-control-orders-what-does-this-mean-for-domestic-industry/20240425.htm

HDFC Bank Q4 performance and future outlook

HDFC Bank Q4 performance and future outlook

Rediff.com30 Apr 2024

HDFC Bank's January-March quarter result, which came in-line with expectations, failed to enthuse investors. The reason? The management's decision to abstain from providing any specific growth guidance, and analysts' expectations of an arduous road to recovery. Analysts believe the path to normalisation of several growth metrics is unlikely to be a straightforward one, and the road to balance sheet realignment may be long.

PSUs in fast lane on capex push, top 10 shares nearly double

PSUs in fast lane on capex push, top 10 shares nearly double

Rediff.com14 Sep 2023

Public-sector enterprise stocks have seen a good run thus far in 2023-24 (FY24), with the S&P BSE PSU Index surging by over 26 per cent during the period, compared to an 11 per cent increase in the benchmark S&P BSE Sensex.

Sun Pharma's growth pill: Specialising in specialty and scaling in India

Sun Pharma's growth pill: Specialising in specialty and scaling in India

Rediff.com25 Mar 2024

Traction for its specialty portfolio, a strong showing in the domestic market, and better regulatory compliance are positives for the country's largest pharmaceutical (pharma) company, Sun Pharmaceutical Industries. Given the triggers, some brokerages have increased their earnings per share estimates and target price for 2024-25 (FY25). This should sustain the momentum for the stock, which has been one of the major pharma gainers in 2023-24 (FY24), rising 57 per cent. It is currently trading at Rs 1,547 per share.

Should you buy stocks of Page Industries?

Should you buy stocks of Page Industries?

Rediff.com31 Mar 2023

Since its October high last year, the stock of innerwear major Page Industries has been on a downtrend, shedding a little over 30 per cent of its market value. Higher competitive intensity, muted volumes, pressure on margins, and rich valuations have led to downgrades for the stock. The October-December quarter (third quarter, or Q3) performance was lower than the Street's expectations - both on volumes/sales and margins.

How paint makers plan to tackle slowdown

How paint makers plan to tackle slowdown

Rediff.com20 Feb 2024

Berger Paints, the country's second-largest decorative paint maker, continued to outperform its peers and gain market share in the 2023-24 (FY24) October-December quarter (third quarter, or Q3). The company posted a consolidated revenue growth of 7 per cent compared to the year-ago quarter, surpassing Asian Paints (5.4 per cent) and Kansai Nerolac Paints (5.7 per cent).

Movie success offsets ad revenue slip for broadcasters like ZEE, Sun TV

Movie success offsets ad revenue slip for broadcasters like ZEE, Sun TV

Rediff.com19 Oct 2023

Notwithstanding record revenues in certain media sectors like film exhibition in the July-September quarter (second quarter, or Q2), the operational performance of the broadcasting business remained subdued. Zee Entertainment Enterprises and Sun TV are expected to experience a year-on-year (Y-o-Y) decline in advertising (ad) revenues during this period. Conversely, box office (BO) collections are anticipated to exceed Rs 3,000 crore in the quarter, propelled by a series of successful movie releases.

ER&D software firms navigate Q2 bends with growth arrows in sight

ER&D software firms navigate Q2 bends with growth arrows in sight

Rediff.com30 Oct 2023

The July-September quarter results of software companies in the engineering research and development (ER&D) segment were broadly in line with expectations, though there have been cuts in revenue growth guidance. While results were a mixed bag, and there are cautionary views on the near-term outlook, brokerages and global consulting firms highlight the strong growth trajectory for the sector. They expect this segment of the software sector to grow by 8-12 per cent going forward.

Hotel stocks to ride the elevator to revenue growth on room rates

Hotel stocks to ride the elevator to revenue growth on room rates

Rediff.com23 Oct 2023

Hotel companies, which have experienced substantial share price gains in the past six months, are not only expected to post robust revenue growth in the seasonally weak July-September quarter (second quarter, or Q2) of 2023-24 (FY24), with the trend continuing in the second half (H2) of FY24, but according to some analysts, they will also benefit from a structural uptrend in progress. To begin with, larger players in the listed hotel sector are expected to report strong growth in Q2 compared to the year-ago quarter. Led by higher demand from the business segment, the sector is expected to achieve a growth rate of 15-30 per cent.

Robust Q2, demand trends to put out welcome mat for realty stocks

Robust Q2, demand trends to put out welcome mat for realty stocks

Rediff.com16 Oct 2023

The S&P BSE Realty Index has emerged as one of the top-performing sectors, yielding a remarkable 45 per cent return over the past six months. The three leading players, listed by market capitalisation, have substantially enriched investor wealth by 43-70 per cent during this period. If the second quarter (Q2) of 2023-24 (FY24) updates from Macrotech Developers (Lodha) and Sobha, along with industry data for the quarter, serve as any indication, the trend of strong bookings for larger players is expected to continue.

'Markets are conflicted on which way to move'

'Markets are conflicted on which way to move'

Rediff.com18 Nov 2022

'Calendar year 2023 is going to be big as pessimism takes a back seat.'

Results preview: India Inc likely to report highly profitable Q4

Results preview: India Inc likely to report highly profitable Q4

Rediff.com18 Apr 2023

Brokerages expect India Inc to report an upturn in earnings for the March quarter of 2022-23, after a relatively muted showing in the previous two quarters. This growth is expected to be led by banking, financial services and insurance (BFSI) companies, FMCG firms, and automobile makers. The combined net profit of the Nifty50 companies (excluding Adani Enterprises) is expected to have grown 15.6 per cent to Rs 1.77 trillion in Q4FY23, from Rs 1.53 trillion a year ago.

Analysts see more pain ahead for auto firms

Analysts see more pain ahead for auto firms

Rediff.com15 Mar 2022

What has hit sentiment further is a draft proposal by the government to increase vehicle insurance premiums for financial year 2022-23 (FY23). Third-party motor insurance premiums have not been increased over the last two years and if this is approved, insurance costs for specific segments could rise by a fifth. The worst impacted is the 350cc and above two-wheeler segment, where premiums are up 21 per cent. Royal Enfield (Eicher Motor) is the market leader in the segment. The premiums in the 150-350cc two-wheeler category are also being inc

10 Safe Stocks To Bet In Volatile Market

10 Safe Stocks To Bet In Volatile Market

Rediff.com20 Mar 2023

10 high dividend paying stocks across sectors that are expected to maintain or even increase their pay-outs in FY23 thanks to faster earnings growth in the last four quarters.

Road will be bumpy for investors in 2019

Road will be bumpy for investors in 2019

Rediff.com29 Dec 2018

'The first half of 2019 could be volatile.' 'In the second half, volatility inducing events should be largely behind us.'

Nirma cements $1.4-bn Lafarge India buyout

Nirma cements $1.4-bn Lafarge India buyout

Rediff.com12 Jul 2016

Ahmedabad-based firm to fund deal through equal amount of equity and debt.